DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Rothenberg ML et al.
Phase III trial of capecitabine + oxaliplatin (XELOX) vs. 5-fluorouracil (5-FU), leucovorin (LV), and oxaliplatin (FOLFOX4) as 2nd-line treatment for patients with metastatic colorectal cancer (MCRC).
Journal of Clinical Oncology 2007; ASCO Annual Meeting Proceedings (Post-Meeting Edition) 2007
25 (Suppl. 18)
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.